Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06875336 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis

Study acronym: mEX-TB
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 13, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This is a prospective, multicenter, observational study (mEX-TB study) of patients with extrapulmonary tuberculosis (EPTB). Adult patients newly diagnosed with EPTB will prospectively be enrolled into the study. Clinical data will be collected using standardized questionnaires over the whole treatment period for each individual. Additionally, body fluids (blood, urine) will be collected and stored in a central biobank. Biomarkers in EPTB patients will be analyzed during the course of therapy and correlated with clinical data. In addition, a healthy control group will be added, to be used primarily as technical controls for complex laboratory procedures such as RNA-seq and T-cell based assays.
Trial Details
NCT Number NCT06875336
Lead Sponsor University of Cologne
Collaborators: University Hospital, Bonn, Research Center Borstel, Johann Wolfgang Goethe University Hospital, Universitätsklinikum Hamburg-Eppendorf, University Hospital Heidelberg, Helmholtz Zentrum München, University Hospital of Cologne
Conditions
(from sponsor)		 Extrapulmonary Tuberculosis
Related terms Tuberculosis, Extrapulmonary
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov